Paul obtained a first class MChem degree in Chemistry from the University of Leeds in 2008, and a PhD in Organic Chemistry from Imperial College London in 2012. He completed post-doctoral studies at the same institution in 2013, where his research was directed towards biomimetic synthesis.
During his PhD, Paul’s research was focussed upon the synthesis of bioactive anti-cancer agents and the total synthesis of natural products. Paul also has industrial experience in the USA, receiving training in computer assisted drug design and the synthesis and development of bioactive antibody-drug conjugates.
Paul joined Elkington + Fife in 2013, and has since gained experience prosecuting applications before the EPO and coordinating with international agents. Paul has also been responsible for drafting numerous patent applications directed towards the protection of new chemical entities and process chemistry methodologies. He also has experience providing freedom-to-operate and infringement and validity opinions.
PhD – Chemistry – Imperial College London
MChem – Chemistry – University of Leeds